Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: Mutational profiling of micro-dissected pre-malignant lesions from archived specimens

Fig. 1

Benchmarking results for sequencing performance. a Experimental design for performance evaluation using a test DNA specimen (* Exome and † Cancer panel). b, c Fraction of targeted bases covered by a minimum of 20 reads (b) and fraction of PCR duplicates (c) observed in whole exome sequencing. d, e Fraction of targeted bases covered by a minimum of 20 reads (d) and fraction of PCR duplicates (e) observed in cancer panel sequencing. All error bars represent standard deviation

Back to article page
\